| Date | Title | Description |
| 27.09.2024 | Navigating the Crossroads of Innovation and Illicit Trade in India | India stands at a pivotal moment. On one side, the promise of innovation in the medical technology sector shines brightly. On the other, a shadow looms over the economy due to rampant illicit trade. These two narratives are intertwined, sha... |
| 27.09.2024 | Everstone-backed medical devices maker Integris appoints new CEO | Probir Das, group CEO, Integris Health Pvt. Ltd
Integris Health Pvt Ltd, which manufactures and distributes cardiac stents and cardiovascular medical devices under the name Translumina Therapeutics, said Friday it has appointed former chief... |
| 11.09.2024 | U.S. and European Patient Monitoring Equipment Market Update: Remote Patient Monitoring, IoT, ASCs, and the Rapid EEG Market | iData Research | VANCOUVER, BC, Sept. 11, 2024 /PRNewswire/ - iData Research, a leading global consulting and market research firm, has released new, in-depth reports on the U.S. and European patient monitoring equipment (PME) markets. The reports highlight... |
| 29.08.2024 | The Surge of Cardiac Surgery: A Market in Motion | The global cardiac surgery market is on the rise. It’s a lifeline in a world grappling with cardiovascular diseases (CVDs). These diseases are silent killers, claiming over 17 million lives each year. As technology advances, the market is p... |
| 28.08.2024 | Cardiac Surgery Market to Exceed $24B Due to Global Shift Towards Minimally Invasive Surgeries (TAVI/TAVR and TMVr) | iData Research | VANCOUVER, BC, Aug. 28, 2024 /PRNewswire/ - In a world, where cardiovascular diseases (CVDs) remain a leading cause of death, the global cardiac surgery market has emerged as a cornerstone of life-saving interventions, driven by innovations... |
| 07.08.2024 | Terumo Ventures: A New Chapter in Medical Innovation | In the bustling world of medical technology, Terumo Corporation is making waves. The company has launched "Terumo Ventures," a Corporate Venture Capital (CVC) arm designed to spearhead its investment strategy. This move is not jus... |
| 06.08.2024 | Terumo Establishes Corporate Venture Capital "Terumo Ventures" | TOKYO, Aug. 6, 2024 /PRNewswire/ -- Terumo Corporation (TSE: 4543) today announced that it has established "Terumo Ventures," a Corporate Venture Capital (CVC) organization responsible for leading the Group's venture investments, ... |
| 05.08.2024 | Terumo Establishes Corporate Venture Capital "Terumo Ventures" | TOKYO, Aug. 5, 2024 /PRNewswire/ -- Terumo Corporation (TSE: 4543) today announced that it has established "Terumo Ventures," a Corporate Venture Capital (CVC) organization responsible for leading the Group's venture investments, ... |
| 10.07.2024 | В Кузнецке появится современный центр сердечно-сосудистой хирургии | - |
| 09.04.2024 | Хотите похудеть – НЕ спрашивайте меня как. Часть 2: Оземпик — опыты на себе | Кратко для лиги лени: Оземпик как средство для похудения работает, но ограниченно годится для ИТ, и дает осечки примерно 50 на 50 побочки.
В первой части я попробовал рассмотреть хоть как-то эффективные методы, кроме «надо меньше есть». Это... |
| 13.03.2024 | Global Pen Needles Market Report 2024-2034: Regional Analysis by Product, Needle Length, Therapy, and Distribution Channel Featuring Novo Nordisk, Terumo Corp, and Roche Diabetes Care Among Others | - |
| 11.03.2024 | Infusion Pump Software Market to Cross USD 1660 Million by 2030 | Infusion Pump Software Market
Infusion Pump Software Market Analysis, Industry Overview and Growth Outlook AUSTIN, TEXAS, UNITED STATES, March 11, 2024 /EINPresswire.com/ -- The Global Infusion Pump Software Market is expected to reach 1660... |
| 08.03.2024 | Industry-Up Day Spring 2024 will be held on March 28th and will be one of the largest exchanges in Japan for the co-creation of new industries and a festival for cross-border human resources. 19 sessi... | SUNDRED Co., Ltd.
Industry-Up Day Spring 2024 will be held on March 28th and will be one of the largest exchanges in Japan for the co-creation of new industries and a festival for cross-border human resources. 19 sessions in total and 32 sp... |
| 08.03.2024 | Surgical Retractors Market to Hit USD 3.17 Billion by 2030 - Exclusive Report by SNS Insider | Surgical Retractors Market
Surgical Retractors Market Analysis, Size, Share, Trends, Industry Overview and Growth Outlook AUSTIN, TEXAS, UNITED STATES, March 8, 2024 /EINPresswire.com/ -- The Global Surgical Retractors Market is expected to... |
| 07.03.2024 | Blood Collection Tubes Market Size is Projected to Reach USD 3.6 billion by 2031, Grow at a 5.4% CAGR| Analysis Report by Transparency Market Research, Inc. | - |
| 05.03.2024 | Veterinary Disposables Global Market Report 2024 | - |
| 01.11.2022 | New Randomized Controlled Study Published in JAMA Demonstrates the Value of Clinical Decision Support Tools in Preventing Acute Kidney Injury in Patients Undergoing Coronary Angiography | – Researchers used Terumo Health Outcomes' ePRISM® software to calculate safe contrast volume targets and improve overall patient outcomes –
SOMERSET, N.J., Nov. 1, 2022 /PRNewswire/ -- A new study published in JAMA[1] demonstrated that pat... |
| 16.05.2022 | Terumo Announces Change in Indication for Dexcom G6 CGM System in Japan | Adjunctive use of Blood Glucose Meter Principally Not Required
TOKYO, May 16, 2022 /PRNewswire/ -- Terumo Corporation (TSE: 4543) today announces that the indication for the Dexcom G6 CGM System has changed in Japan as of May 10, 2022. With... |
| 01.03.2022 | Terumo Establishes Group-wide 'DE&I Philosophy' to Further Cultivate a Diverse, Equitable and Inclusive Culture | TOKYO, Mar. 1, 2022 /PRNewswire/ -- Terumo Corporation (TSE: 4543) today announced that it has established a global "DE&I Philosophy" to further cultivate the culture of Diversity, Equity, and Inclusion (DE&I) at the Terum... |
| 25.02.2022 | Terumo and Corazon Sign Collaboration and Co-Marketing Agreement | SOMERSET, N.J., Feb. 25, 2022 /PRNewswire/ -- Terumo Health Outcomes, a division of Terumo Medical Corporation, a leading global medical device manufacturer, has signed a collaboration and co-marketing agreement with Corazon, Inc., a leader... |
| 09.02.2022 | Terumo : to Implement New Executive Officers' Management System | February 9, 2022
TOKYO, JAPAN - February 9, 2022 - Terumo Corporation (TSE: 4543) today announced that in conjunction with the new 5-Year Growth Strategy with a 10-Year Vision (GS26) starting next fiscal year, the company will implement a n... |
| 12.01.2022 | Terumo Medical Corporation Applauds ACC/AHA/SCAI Decision to Designate Radial Access Class 1, Level of Evidence A | SOMERSET, N.J., Jan. 12, 2022 /PRNewswire/ -- Terumo Medical Corporation (TMC) applauds the publication of updated guidelines from the American College of Cardiology (ACC), American Heart Association (AHA) and the Society for Cardiovascular... |
| 20.12.2021 | Terumo : Establishes "Terumo Group Sustainability Policy" and Revises the Sustainability PrioritiesTo realize “Advancement of Healthcare” and “Enhancement of Patients' QOL” | December 20, 2021
TOKYO, JAPAN - December 20, 2021 - Terumo Corporation (TSE: 4543) today announced that Terumo Group Sustainability Policy has been established. In accordance, the sustainability priorities for the Group have been revised.
... |
| 20.12.2021 | Terumo : Corporate Governance Report | Corporate Governance
TERUMO CORPORATION
Last update: December 20th, 2021
Terumo Corporation
Representative: Shinjiro Sato, President and CEO
Contact: Kenichi Hata, General Manager
Investor Relations Dept.
Tel.: 81-3-6742-8550
Stock code: 45... |
| 20.12.2021 | Terumo : "Q&A Session at the 5-Year Growth Strategy with a 10-Year Vision"(288.1 KB) | Among the information that Terumo discloses, the forward-looking statements including financial projections are based upon our assumptions using information available to us at the time and are not intended to be guarantees of future events ... |
| 16.12.2021 | Terumo : "Corporate"(6.2 MB) | Celebrating our 100th founding anniversary: 5-Year Growth Strategy with a 10-Year Vision
05 | Corporate
Fumihisa Hirose,
General Manager, Strategic Planning Dept. and CTO
Safe Harbor for Forward-Looking Statements and Use of Document
Among ... |
| 16.12.2021 | Terumo : "Blood and Cell Technologies Company" | Celebrating our 100th founding anniversary: 5-Year Growth Strategy with a 10-Year Vision
04 | Terumo Blood and Cell Technologies
Antoinette Gawin, President
Safe Harbor for Forward-Looking Statements and Use of Document
Among the informatio... |
| 16.12.2021 | Terumo : Announces 5-Year Growth Strategy (GS26) to Deliver Solutions to 21st Century Healthcare Challenges | Terumo Announces 5-Year Growth Strategy (GS26) to Deliver
Solutions to 21st Century Healthcare Challenges
TOKYO, JAPAN - December 16, 2021 - Terumo Corporation (TSE: 4543) today announced its new 5-Year Growth strategy (GS26*1) for the fisc... |
| 10.12.2021 | Terumo : Aortic Announces PMDA Approval for RelayPro Endovascular Device in Japan | December 10, 2021
Terumo Aortic today announced that the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) has granted approval of the RelayPro Thoracic Stent-Graft System for sale in Japan for the treatment of patients with thorac... |
| 09.12.2021 | Terumo : Aortic Announces Launch and First Commercial Use of the Aortic Balloon Device | December 8, 2021
Terumo Aortic today announced the launch and first commercial case of the Aortic Balloon in the United States. The device assists physicians in the expansion of the aorta when using TREO and RELAY stent-grafts in endovascul... |
| 30.11.2021 | Q-Sera enters exclusive agreement with Terumo Corporation for RAPClot™ rapid serum blood collection tube technology in Japan | MELBOURNE, Australia, Nov. 30, 2021 /PRNewswire/ -- Q-Sera Pty Ltd, an Australian venture-backed company, today announced a partnership with Terumo Corporation, the leading Japanese medical device company, which will see its patent protecte... |
| 17.11.2021 | Terumo : and Diabeloop SA. Enter into Comprehensive Strategic Partnership Agreement to Expand Their Diabetes Care Offerings | November 17, 2021
TOKYO, JAPAN and PARIS, FRANCE - November 17, 2021 - Terumo Corporation, a global leader in medical technology and the French company Diabeloop, a pioneer in therapeutic AI, announced today that they have signed an agreeme... |
| 08.11.2021 | Terumo Report 2021 | Terumo Report 2021
Group Mission
Contributing to Society through Healthcare
We contribute to society by providing valued products and services in the healthcare market and by responding to the needs of patients and healthcare professionals.... |
| 08.11.2021 | Terumo to Develop Smartphone-type Device to Control Insulin Pump | November 8, 2021
TOKYO, JAPAN - November, 8 2021 - Terumo Corporation (TSE: 4543) today announced that it has partnered with an European company to co-develop a new technology to enable MEDISAFE WITH insulin patch pump to be controlled by a... |
| 05.11.2021 | "Financial Results for the First Half of FYE 3/2022"（with note）(1.0 MB) | Financial Results for the First Half of
Fiscal Year Ending March 31, 2022 (FY2021)
November 4, 2021
Naoki Muto
Chief Accounting and Financial Officer
Terumo Corporation
I am the CAFO, Muto. I will now explain the 2nd-quarter results for the... |
| 22.10.2021 | Terumo : Aortic Announces PMDA Approval and First Commercial Implant of TREO Endovascular Device in Japan | October 22, 2021
Following the recent approval by the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) of the TREO Abdominal Aortic Stent-Graft System for sale in Japan for the treatment of patients with abdominal aortic aneurysms... |
| 22.10.2021 | Terumo : Blood and Cell Technologies Opens Manufacturing Facility in Costa RicaThe company will offer 700 new jobs in diverse fields | October 21, 2021
●The $60 million USD expansion demonstrates the company's continued investment to support its global supply chain spanning 130 countries.
●The world-class manufacturing plant will produce medical devices that collect and se... |
| 05.10.2021 | Terumo : Aortic Announces First Implant of Landmark Thoracoabdominal Hybrid Device | October 4, 2021
Terumo Aortic today announced the successful implantation of the company's first custom made thoracoabdominal hybrid device to treat thoracoabdominal aortic disease.
The world's first thoracoabdominal repair procedure using ... |
| 22.09.2021 | Terumo : CVS Fully Exits Consent Decree | September 21, 2021
Tokyo - Terumo Corporation (TSE: 4543) announced today that the Ann Arbor plant of its U.S. subsidiary, Terumo Cardiovascular Systems (hereafter Terumo CVS) is no longer under a consent decree with the United States feder... |
| 22.09.2021 | Terumo : Aortic Announces Launch of Landmark Global Surgical Graft Study | September 21, 2021
Terumo Aortic today announced the launch of the company's global surgical graft study known as PANTHER. This study is aprospective and retrospective, multi-centre, multi-arm, post-market study of the company's comprehensi... |
| 21.09.2021 | Terumo : India releases Special Postal Cover and My Stamp to Commemorate 100 years of Terumo Corporation | September 21, 2021
NEW DELHI - September 21, 2021 - Terumo India, the Indian arm of Terumo Corporation (TSE: 4543), a global leader in medical technology, celebrated the centenary anniversary of its founding day through an official release ... |
| 21.09.2021 | Terumo : Celebrates 100-Year Anniversary in Asia with an Eye to the Future | September 20, 2021
SINGAPORE - September 20, 2021 - Terumo, a global leader in medical technology, celebrates its centenary in Asia. From humble beginnings as a thermometer manufacturer in 1921, and the first company in 1963 to create dispo... |
| 20.09.2021 | Terumo celebrates 100-year anniversary in Asia with an eye to the future | SINGAPORE, Sept. 20, 2021 /PRNewswire/ -- Terumo, a global leader in medical technology, celebrates its centenary in Asia. From humble beginnings as a thermometer manufacturer in 1921, and the first company in 1963 to create disposable syri... |
| 17.09.2021 | Terumo Celebrates 100th Anniversary of Contributing to Society Through Healthcare | TOKYO, Sept. 17, 2021 /PRNewswire/ -- Terumo Corporation (TSE: 4543), a global leader in medical technology, today celebrates its 100th anniversary. The company, based in Tokyo, boasts over 25,000 associates worldwide, providing products an... |
| 14.07.2021 | Terumo Introduces New AZUR™ Vascular Plug and PG Pro™ Peripheral Microcatheter Embolization System | SOMERSET, N.J., July 14, 2021 /PRNewswire/ -- Terumo Medical Corporation (TMC) has announced today the introduction of its AZUR™ Vascular Plug, the first and only plug compatible with a microcatheter to occlude arteries up to 8mm in diamete... |
| 14.05.2021 | Terumo Donates Additional USD 1 Million to Support the COVID-19 Solidarity Response Fund for WHO | TOKYO, May 14, 2021 /PRNewswire/ -- As the world joins together to fight the ongoing battle against the COVID-19 pandemic, Terumo Corporation (TSE: 4543) has announced that the Terumo Group companies will collectively donate USD 1 million i... |
| 15.04.2021 | TERUMO CORPORATION
Terumo : Corporate Governance Report | Corporate Governance
TERUMO CORPORATION
Last update: April 15th, 2021
Terumo Corporation
Representative: Shinjiro Sato, President and CEO
Contact: Kenichi Hata, General Manager
Investor Relations Dept.
Tel.: 81-3-6742-8550
Stock code: 4543
... |
| 23.02.2021 | Terumo Signs a Definitive Agreement to Acquire All Assets of Health Outcomes Sciences, Inc. | |
| 04.12.2020 | Growing And Thriving By Simplifying: Inside Terumo’s Transformation | In 2018, top leaders at Terumo Medical Corporation, a leading manufacturer of medical devices and supplies, needed solutions to streamline and simplify their growing business. After steadily building a reputation for producing innovative pr... |
| 01.05.2017 | Launch Capital Joins $3M Series A for ReThink Medical | ReThink Medical, a leading data-driven heart failure medical device and digital health company, announced today a Series A investment of $3 million led by medical device equity firm Emergent Medical Partners (EMP). EMP will lead the round w... |
| 01.05.2017 | Norwich Ventures Joins $3M Series A for ReThink Medical | ReThink Medical, a leading data-driven heart failure medical device and digital health company, announced today a Series A investment of $3 million led by medical device equity firm Emergent Medical Partners (EMP). EMP will lead the round w... |
